Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia
Key facts
- Who runs it
- Mst.Sumyara Khatun
- Where
- Bangladesh1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 56 people, planned
- Started
- 1 Oct 2025
- Expected to end
- 1 Mar 2027
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Coenzyme Q 10
- Pentoxifylline 400 MG Oral Tablet
- Record updated
- 26 November 2025
Who can take part
- Age
- 20 years to 50 years
- Sex
- Men only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 11 criteriaShow less
Who can take part
- Sub fertile men with asthenozoospermia(Total motility20% to less than 42%) according to WHO semen analysis,2021
- Age 20-50 years
Who cannot take part
- Drug, alcohol or substance abuse, psycho-sexual abnormalities
- Drug, alcohol or substance abuse, psycho-sexual abnormalities
- Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery
- Any known hypersensitivity to xanthine related product, recent cerebral or retinal haemorrhage Severe oligoasthenoteratozoospermia
- Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery
- Any known hypersensitivity to xanthine related product, recent cerebral or retinal haemorrhage
- Severe oligoasthenoteratozoospermia
- Antioxidants supplmentation in the last 3 months
- Antioxidants supplmentation in the last 3 months
The main criteria, as questions
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 20 and 50 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if drug Pentoxifylline plus Coenzyme Q10 work to treat asthenozoospermia in subfertile male. It will also learn about the safety of drug Pentoxifylline plus Coenzyme Q10. The main questions it aims to answer are:
Read full original descriptionShow less
Does drug Pentoxifylline plus Coenzyme Q10 increase the motility of sperm in participants? What medical problems do participants have when taking drug Pentoxifylline plus Coenzyme Q10 ? Researchers will compare drug Pentoxifylline plus Coenzyme Q10 combination to Coenzyme Q10 alone to see if drug Pentoxifylline plus Coenzyme Q10 combination works better.
Participants will:
Experimental Group:Pentoxifylline 400mg twice dailyand Coenzyme Q10 100mg twice daily for 3 months.
Comparator Group: Coenzyme Q10 100mg twice daily for 3 months Visit the clinic after three months of treatment for checkups and tests
The 2 groups in the trial
- Experimental (PTX+ CoQ10)Treatment being tested
Participants receive pentoxifylline 400mg orally twice daily plus Coenzyme Q10 100mg twice daily orally
Treatment: Pentoxifylline 400 MG Oral Tablet
- Active Comparator (Coenzyme Q10)Existing treatment, for comparison
Participants receive Coenzyme Q10 100mg twice daily orally
Treatment: Coenzyme Q 10
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Pentoxifylline Plus Coenzyme Q10 Combination Therapy Compared to Coenzyme Q10 Alone on Sperm Motility in Sub-fertile Male With Asthenozoospermia
- Criteria questions
- Built from NCT07252518, who can take part
- Record updated
- 26 November 2025